Detection of Biomarkers for Epithelial-Mesenchymal Transition with Single-Cell Trajectory Inference

被引:1
|
作者
Murayama, Kosho [1 ]
Matsuda, Hideo [1 ]
机构
[1] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2022年 / 27卷 / 04期
关键词
pseudotime analysis; trajectory inference; single-cell RNA-seq; epithelial-mesenchymal transition; LYMPHOTOXIN;
D O I
10.31083/j.fbl2704127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Epithelial-mesenchymal transition (EMT) has been recognized as playing a crucial role in cancer progression. Among the studies on EMT, biomarker detection has been one of the important topics to understand the biology and mechanism of EMT related to tumor progression and treatment resistance. The existing methods often identified differentially-expressed genes as potential markers by ranking all genes by their variances. This paper proposes a novel method to detect markers for respective lineages in the EMT process. Methods and Results: Our method consists of three steps: first, perform trajectory inference to identify the lineage of transitional processes in EMT progression, and secondly, identify the lineage for EMT reversion in addition to EMT progression, and thirdly detect biomarkers for both of the EMT progression and reversion lineages with differential expression analysis. Furthermore, to elucidate the heterogeneity of the EMT process, we performed a clustering analysis of the cells in the EMT progression and reversion conditions. We then explored branching trajectories that order clusters using time information of the time-course samples. Using this method, we successfully detected two potential biomarkers related to EMT, phospholipid phosphatase 4 (PLPP4) and lymphotoxin-beta (LTB), which have not been detected by the existing method. Conclusions: In this study, we propose a method for the detection of biomarkers of EMT based on trajectory inference with single-cell RNA-seq data. The performance of the method is demonstrated by the detection of potential biomarkers related to EMT.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] A comparison of single-cell trajectory inference methods
    Saelens, Wouter
    Cannoodt, Robrecht
    Todorov, Helena
    Saeys, Yvan
    NATURE BIOTECHNOLOGY, 2019, 37 (05) : 547 - 554
  • [22] Epithelial-mesenchymal transition and the stem cell phenotype
    Radisky, Derek C.
    LaBarge, Mark A.
    CELL STEM CELL, 2008, 2 (06) : 511 - 512
  • [23] Epithelial-Mesenchymal Transition
    Zavadil, Jiri
    Haley, John
    Kalluri, Raghu
    Muthuswamy, Senthil K.
    Thompson, Erik
    CANCER RESEARCH, 2008, 68 (23) : 9574 - 9577
  • [24] Epithelial-mesenchymal transition
    Kubik, Joanna
    Pawlak, Kamil
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2023, 36 (01) : 18 - 20
  • [25] Epithelial-mesenchymal transition
    Radisky, DC
    JOURNAL OF CELL SCIENCE, 2005, 118 (19) : 4325 - 4326
  • [26] Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
    Tsuji, Takanori
    Ibaragi, Soichiro
    Hu, Guo-fu
    CANCER RESEARCH, 2009, 69 (18) : 7135 - 7139
  • [27] Critical biomarkers of epithelial-mesenchymal transition in the head and neck cancers
    Natarajan, Jayalakshmi
    Chandrashekar, Chetana
    Radhakrishnan, Raghu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (03) : 512 - 518
  • [28] Epithelial-mesenchymal Transition (EMT) Molecular Biomarkers in Malignant IPMN
    Lahat, G. J.
    Lowenstein, S.
    Nachmany, I.
    Benhaim, M.
    Nakache, R.
    Santo, I.
    Inbar, M.
    Halperin, Z.
    Klausner, J. M.
    Lubezky, N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S9 - S9
  • [29] Biomarkers for epithelial-mesenchymal transitions
    Zeisberg, Michael
    Neilson, Eric G.
    JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06): : 1429 - 1437
  • [30] Single-cell qPCR demonstrates that Repsox treatment changes cell fate from endoderm to neuroectoderm and disrupts epithelial-mesenchymal transition
    Li, Qiuhong
    Huang, Qingsong
    PLOS ONE, 2019, 14 (10):